Heat shock protein inhibitors and vaccines as new agents in cancer treatment
Authors:
- 21 January 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 18 (2) , 161-174
Abstract
Heat shock proteins (HSP) play an essential role as molecular chaperones by assisting correct holding and folding in human cells. At the same time they present implications in tumor cell proliferation, differentiation, matrix invasion, angiogenesis, metastasis and cell death. They also possess the ability to present tumor molecules to the immune system and elicit an immune response. New agents targeting HSP, as anticancer treatment, are under clinical evaluation. The aim of this review is to explore the role of HSP90 inhibitors as anticancer agents as well as to evaluate the benefit from the use of autologous HSP vaccines in both the adjuvant setting and first-line treatment. The latest evidence regarding the use of geldanamycin analogues or newer water-soluble and synthetics molecules that inhibit the binding of HSP90 to client proteins was reviewed. Immunization using tumor-derived HSP in several cancer types was also evaluated. HSP90 inhibitors represent a promising therapeutic option although further evaluation in larger clinical trials is needed. On the other hand, HSP vaccination has already an established role in our armory against cancer.Keywords
This publication has 79 references indexed in Scilit:
- Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findingsBritish Journal of Cancer, 2008
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced MalignanciesJournal of Clinical Oncology, 2005
- Chaperons moléculaires et repliement des protéines : L’exemple de certaines protéines de choc thermiquemédecine/sciences, 2005
- Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemiaCardiovascular Research, 2005
- Induction of Angiogenesis by Heat Shock Protein 90 Mediated by Protein Kinase Akt and Endothelial Nitric Oxide SynthaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Pathways of chaperone-mediated protein folding in the cytosolNature Reviews Molecular Cell Biology, 2004
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- A Novel Association between the Human Heat Shock Transcription Factor 1 (HSF1) and Prostate AdenocarcinomaThe American Journal of Pathology, 2000
- Geldanamycin-Induced Destabilization of Raf-1 Involves the ProteasomeBiochemical and Biophysical Research Communications, 1997
- Heat Shock Transcription Factors: Structure and RegulationAnnual Review of Cell and Developmental Biology, 1995